ZA201204622B - Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue - Google Patents

Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue

Info

Publication number
ZA201204622B
ZA201204622B ZA2012/04622A ZA201204622A ZA201204622B ZA 201204622 B ZA201204622 B ZA 201204622B ZA 2012/04622 A ZA2012/04622 A ZA 2012/04622A ZA 201204622 A ZA201204622 A ZA 201204622A ZA 201204622 B ZA201204622 B ZA 201204622B
Authority
ZA
South Africa
Prior art keywords
analogue
vitamin
derivative
pharmaceutical composition
solvent mixture
Prior art date
Application number
ZA2012/04622A
Other languages
English (en)
Inventor
Karsten Petersson
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of ZA201204622B publication Critical patent/ZA201204622B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2012/04622A 2009-12-22 2012-06-21 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue ZA201204622B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK2009000264 2009-12-22
US29310810P 2010-01-07 2010-01-07
PCT/DK2010/000184 WO2011076209A2 (en) 2009-12-22 2010-12-22 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue

Publications (1)

Publication Number Publication Date
ZA201204622B true ZA201204622B (en) 2013-09-25

Family

ID=43618136

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/04622A ZA201204622B (en) 2009-12-22 2012-06-21 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue

Country Status (14)

Country Link
US (1) US20130023501A1 (enExample)
EP (1) EP2515866B1 (enExample)
JP (1) JP5732471B2 (enExample)
CN (1) CN102770121B (enExample)
AU (1) AU2010335656B2 (enExample)
BR (1) BR112012015437A2 (enExample)
CA (1) CA2785254A1 (enExample)
ES (1) ES2452872T3 (enExample)
IL (1) IL220517A (enExample)
MX (1) MX2012007225A (enExample)
NZ (1) NZ601001A (enExample)
RU (1) RU2559084C2 (enExample)
WO (1) WO2011076209A2 (enExample)
ZA (1) ZA201204622B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105188686A (zh) * 2013-02-27 2015-12-23 劳瑞·罗伯特·巴特 透皮制剂
KR102486797B1 (ko) * 2016-03-09 2023-01-11 삼성전자 주식회사 전자 장치 및 전자 장치의 디스플레이 구동 방법
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
CN106265485A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种稳定性改善的卡泊三醇组合物
CN106265511A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种性能优异的卡泊三醇倍他米松自微乳制剂
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
JP7818752B2 (ja) * 2019-10-25 2026-02-24 カーディオル セラピューティクス インコーポレイテッド 心臓病態の治療に使用するためのカンナビジオール組成物
CN116600786A (zh) 2020-07-28 2023-08-15 阿尔库缇斯生物疗法股份有限公司 含有jak抑制剂和月桂醇聚醚-4的局部制剂
JP2024544404A (ja) 2021-12-15 2024-11-29 アーキュティス・バイオセラピューティクス・インコーポレーテッド Ｓｈｒ０３０２の安定な製剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
USRE39706E1 (en) 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
GB9611603D0 (en) * 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
ES2388425T5 (es) * 1999-04-23 2020-02-12 Leo Pharma As Composición farmacéutica no acuosa para uso dérmico para tratar la psoriasis que comprende una vitamina D, un corticoesteroide y un componente disolvente
MXPA04005260A (es) * 2001-12-03 2005-03-23 Novacea Inc Composiciones farmaceuticas que comprenden compuestos activos de vitamina d.
US7977387B2 (en) 2003-07-24 2011-07-12 Leo Pharma A/S Aminobenzophenone compounds
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
CN101115728B (zh) 2004-12-13 2012-12-19 利奥制药有限公司 三唑取代的氨基二苯甲酮化合物
FR2887150B1 (fr) * 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
AU2007336538B2 (en) 2006-12-22 2012-04-05 Leo Pharma A/S Substituted acetophenones useful as PDE4 inhibitors
KR101571654B1 (ko) 2007-02-28 2015-11-25 레오 파마 에이/에스 신규한 포스포디에스테라제 억제제
US7909624B2 (en) 2007-03-26 2011-03-22 Belkin International, Inc. Carabiner universal serial bus hub
CA2688670A1 (en) 2007-04-19 2008-10-30 Leo Pharma A/S Src family kinase inhibitors
ES2401205T3 (es) * 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
JP2010526824A (ja) 2007-05-11 2010-08-05 ソネボーン インコーポレイテッド シリコーン類似の特性を有するワセリン
SG172206A1 (en) 2008-12-19 2011-07-28 Leo Pharma As Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases

Also Published As

Publication number Publication date
NZ601001A (en) 2014-07-25
IL220517A (en) 2016-08-31
AU2010335656B2 (en) 2015-05-07
CA2785254A1 (en) 2011-06-30
CN102770121A (zh) 2012-11-07
WO2011076209A3 (en) 2012-02-23
MX2012007225A (es) 2012-07-30
WO2011076209A2 (en) 2011-06-30
JP5732471B2 (ja) 2015-06-10
EP2515866A2 (en) 2012-10-31
RU2012130411A (ru) 2014-01-27
HK1177696A1 (en) 2013-08-30
CN102770121B (zh) 2014-10-15
US20130023501A1 (en) 2013-01-24
RU2559084C2 (ru) 2015-08-10
JP2013515020A (ja) 2013-05-02
AU2010335656A1 (en) 2012-07-19
IL220517A0 (en) 2012-08-30
ES2452872T3 (es) 2014-04-03
EP2515866B1 (en) 2014-02-19
BR112012015437A2 (pt) 2016-03-15

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and its administration
ZA201208281B (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
IL220517A0 (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
GB2450753B (en) New Pharmaceutical formulation
IL211683A0 (en) 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
IL199853A (en) Converged history of 5-Hydroxy-Admentil-2-Reindeer and Pharmaceutical Preparation containing them
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
ZA201204619B (en) Pharmaceutical composition comprising vitamin d analogue and cosolventsurfactant mixture
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
SI2318419T1 (sl) Spojine boronat estra in njihovi farmacevtski sestavki
ZA201207839B (en) Pharmaceutical composition comprising a pyrimidineone derivative
IL217762A0 (en) Pharmaceutical formulation
IL213712A0 (en) Alkaloid aminoester derivatives and medicinal composition thereof
ZA201204620B (en) Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
ZA201201727B (en) Indenone derivative and pharmaceutical composition comprising same
HU0900072D0 (en) Transdermal pharmaceutical compositions
IL210446A (en) History of fibrin and medicinal preparations containing them
ZA201200079B (en) Pharmaceutical compositions and solid forms
ZA201103347B (en) Pharmaceutical aerosol composition
IL216462A (en) Pharmaceuticals containing nitrile history and uses
ZA201101053B (en) Pharmaceutical compositions of samatotrophic hormones
GB0902648D0 (en) Pharmaceutical compounds and compositions
GB0908317D0 (en) Pharmaceutical compounds and compositions
EP2124931A4 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING NEBIVOLOL OR AN ANALOGUE OF NEBIVOLOL